Literature DB >> 11117589

Health care utilization by people with multiple sclerosis in The Netherlands: results of two separate studies.

P Moorer1, T H Suurmeijer, C P Zwanikken.   

Abstract

PURPOSE: For chronically ill persons it is assumed that they make heavy demands on health care services. In the literature one hardly finds any publications to substantiate or refute this assumption. The main purpose of our study is to describe the health care utilization of people with multiple sclerosis (MS) in the Netherlands and its relationships with severity and duration of the disease.
METHODS: Two different samples of persons with MS were used. In the first sample (University Hospital Groningen) severity of MS was based on medical judgement, while in the second sample (Dutch Multiple Sclerosis Society) severity was self-reported. In both samples, use of health care facilities was assessed with a mail questionnaire.
RESULTS: The methods for determining severity resulted in different distributions for severity of MS. However, the results were quite similar with respect to health care utilization. It appeared that the severity of MS was related to the number of professional caretakers MS-patients had contact with during one year. Duration of MS seemed not to be related to the number of caretakers. Only for specific caretakers, most notably GP, physiotherapist, home help and ergotherapist, the contact frequency increased with severity of MS. No such relationship was found between the frequency of contact with the neurologist and severity of MS.
CONCLUSIONS: People with MS do not make a heavy demand on health care facilities in general but only on certain health care provisions. This is in contrast with the general notion that all chronically ill make a heavy demand on health care facilities in general.

Entities:  

Mesh:

Year:  2000        PMID: 11117589     DOI: 10.1080/09638280050191963

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  5 in total

1.  Multiple sclerosis and rehabilitation: an overview of the different rehabilitation settings.

Authors:  Andrea Tacchino; Giampaolo Brichetto; Paola Zaratin; Mario Alberto Battaglia; Michela Ponzio
Journal:  Neurol Sci       Date:  2017-09-15       Impact factor: 3.307

2.  Needs of Persons with Neurological Disorders.

Authors:  E Sinu; B P Nirmala; Krishna Reddy; Priya Thomas
Journal:  Indian J Psychiatr Soc Work       Date:  2018-01

3.  Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA).

Authors:  Georgios Hadjigeorgiou; Efthimios Dardiotis; Georgios Tsivgoulis; Triantafyllos Doskas; Damianos Petrou; Nikolaos Makris; Nikolaos Vlaikidis; Thomas Thomaidis; Athanasios Kyritsis; Nikolaos Fakas; Xoulietta Treska; Clementine Karageorgiou; Stefania Sotirli; Christos Giannoulis; Dimitra Papadimitriou; Ioannis Mylonas; Evaggelos Kouremenos; Georgios Vlachos; Dimitrios Georgiopoulos; Despoina Mademtzoglou; Michalis Vikelis; Elias Zintzaras
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

4.  The organisation of physiotherapy for people with multiple sclerosis across Europe: a multicentre questionnaire survey.

Authors:  Kamila Rasova; Jenny Freeman; Patricia Martinkova; Marketa Pavlikova; Davide Cattaneo; Johanna Jonsdottir; Thomas Henze; Ilse Baert; Paul Van Asch; Carme Santoyo; Tori Smedal; Antonie Giæver Beiske; Małgorzata Stachowiak; Mariusz Kovalewski; Una Nedeljkovic; Daphne Bakalidou; José Manuel Alves Guerreiro; Ylva Nilsagård; Erieta Nikolikj Dimitrova; Mario Habek; Kadriye Armutlu; Cécile Donzé; Elaine Ross; Ana Maria Ilie; Andrej Martić; Anders Romberg; Peter Feys
Journal:  BMC Health Serv Res       Date:  2016-10-06       Impact factor: 2.655

Review 5.  Occupational therapy for multiple sclerosis.

Authors:  E M J Steultjens; J Dekker; L M Bouter; M Cardol; J C M Van de Nes; C H M Van den Ende
Journal:  Cochrane Database Syst Rev       Date:  2003
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.